11 unknown. 11 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Unknown 11 |
| Phase 3 | 1 | Unknown 1 |
Follow Foot Diseases: new trials by email Literature Review of Foot Diseases trials Research Report on Foot Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Novel Approach to Plantar Fasciitis in the Aging Population minimal shoes and foot strengthening and flexibility exercises, Supportive Footwear, foot orthotic device and foot flexibility exercises - Plantar Fasciitis, Chronic | Phase 2 | Unknown | University of South Florida | 138 | 2023-08-07 | 2024-05-21 |
| Painless Sharp Wound Debridement With Lidocaine-23%-Tetra-caine-7% Gel Versus EMLA 5% Cream IMP2 (lidocaine-23%-tetracaine-7% gel), IMP1 (EMLA 5% cream) - Ulcus Cruris, Ecthyma | Phase 2 | Unknown | Juerg Hafner | 40 | 2023-06-01 | 2023-06-06 |
| Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers Deferoxamine, Placebo - Diabetic Foot Ulcer | Phase 2 | Unknown | Karolinska University Hospital | 174 | 2022-12-30 | 2022-05-26 |
| A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis DBI-001 Gel, DBI-002 Gel, Aqueous Gel - Tinea Pedis | Phase 2 | Unknown | DermBiont, Inc. | 24 | 2022-09-08 | 2023-02-14 |
| Evaluating the Safety and Effect of abobotulinumtoxinA in the Gastrocnemius Muscle to Improve Equinus and Plantar Fasciitis Pain AbobotulinumtoxinA 300 UNT - Plantar Fasciitis, Plantar Fasciitis, Chronic | Phase 2 | Unknown | University Foot and Ankle Foundation | 30 | 2019-11-20 | 2020-09-24 |
| SINGLE-APPLICATION TERBINAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION VERSUS A SINGLE-APPLICATION BUTENAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION FOR THE TREATMENT OF TINEA PEDIS TERBINAFINE HYDROCHLORIDE (1%), BUTENAFINE HYDROCHLORIDE (1%), Vehicle Control - Tinea Pedis | Phase 2 | Unknown | United Laboratories | 42 | 2019-01-02 | 2019-06-26 |
| Effect of Extracorporeal Shock Wave Therapy of Gastrosoleus Trigger Points in Patients With Plantar Fasciitis Extracorporeal shock wave therapy 1, Extracorporeal shock wave therapy 2 - Plantar Fasciitis | Phase 2 / Phase 3 | Unknown | Isfahan University of Medical Sciences | 48 | 2012-11-01 | 2013-02-07 |
| Ulcer Monitoring in Diabetes Mellitus telemedicine consultations - Diabetes Mellitus, Foot Ulcers | Phase 2 | Unknown | Johnny Froekjaer | 400 | 2011-04-01 | 2013-06-05 |
| Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers HO/03/03 10µg, Placebo - Diabetic Foot Ulcer | Phase 2 | Unknown | HealOr | 196 | 2010-02-01 | 2013-04-04 |
| Safety & Efficacy Study for the Use of Extracorporeal Shockwaves in the Treatment of Diabetic Foot Ulcers Extracorporeal Shockwaves - Chronic Diabetic Foot Ulcers | Phase 2 | Unknown | Tissue Regeneration Technologies | 200 | 2006-03-01 | 2006-08-18 |
| Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers KC-002, Conventional Wound Therapy - Foot Ulcer, Diabetes | Phase 2 | Unknown | KeraCure | 300 | 2006-01-01 | 2008-08-26 |
Foot Ulcer (6) · Diabetes Mellitus (5) · Diabetic Foot (3) · Fasciitis, Plantar (3) · Tinea Pedis (2) · Ecthyma (1) · Leg Ulcer (1) · Pain (1) · Varicose Ulcer (1)
Skin Diseases (8) · Skin and Connective Tissue Diseases (8) · Skin Ulcer (6) · Endocrine System Diseases (5) · Glucose Metabolism Disorders (5) · Leg Ulcer (5) · Metabolic Diseases (5) · Nutritional and Metabolic Diseases (5) · Cardiovascular Diseases (4) · Vascular Diseases (4) · Bacterial Infections and Mycoses (3) · Diabetes Complications (3) · Diabetic Angiopathies (3) · Diabetic Neuropathies (3)
BANG polymer gel (1) · Deferoxamine (1) · Foot Orthoses (1) · IGF2BP2 protein, human (1) · Lidocaine, Prilocaine Drug Combination (1) · Terbinafine (1) · butenafine (1) · signal peptide peptidase (1)
DermBiont, Inc. (1) · HealOr (1) · Isfahan University of Medical Sciences (1) · Johnny Froekjaer (1) · Juerg Hafner (1) · Karolinska University Hospital (1) · KeraCure (1) · Tissue Regeneration Technologies (1) · United Laboratories (1) · University Foot and Ankle Foundation (1) · University of South Florida (1)
United States (6) · Denmark (1) · India (1) · Iran (1) · Philippines (1) · Switzerland (1)
Babak Baravarian, DPM (1) · Benjamin S. Rasmussen, MD (1) · Emma Taylor, Ph.D (1) · Farnaz Dehghan, MD (1) · Johnny Froekjaer, MD (1) · Knud B. Yderstraede, MD (1) · Sergiu Catrina, MD/Ass.Prof. (1)
PMID 11991474, PMID 16556754, PMID 21255460, PMID 22349369, PMID 26116717, PMID 27638453
R01AG071646 (1)